Under MAR, issuers, their Persons Discharging Managerial Responsibilities (PDMRs), and their Persons Closely Associated (PCAs) all have important compliance obligations. One key obligation is for the issuer to maintain a list of PDMRs and PCAs. Setting aside familial associations, this article focuses on legal entities (typically companies) as PCAs, or PCA entities.
Definition of PCA Entities under MAR
The MAR (Art. 3(1)(26)) definition of a PCA entity can be complex, and the ESMA Q&A Q7.7 (updated 23 June 2022) provides limited clarification. In short, a PCA entity exists when the issuer’s PDMR (or an individual PCA to such PDMR) fulfills any of the following conditions:
- Directly or Indirectly Controls the Entity
- Has Had the Entity Set Up for Their Benefit
- Has Substantially Equivalent Economic Interests to the Entity
- Takes Part in or Influences the Entity to Transact in the Issuer’s Instruments
Fulfilling any of these four conditions classifies an entity as a PCA entity.
Details of PCA Requisites
1. Control of the Entity
- Requisite 1 generally refers to situations where a PDMR has majority voting rights or effectively controls the entity. This could involve different ownership structures, such as pyramid or shareholder agreements.
- Determining indirect control can vary by country. For instance, a company owning 51% of another company, which in turn owns 51% of the entity, may constitute indirect control.
- There are challenges in determining control when there is no clear majority owner or ultimate beneficial owner (UBO), particularly when ownership is dispersed. The EU 4th Anti-Money Laundering Directive and its 25% threshold may influence such determinations.
2. Entity Set Up for the Benefit of a PDMR
- Requisite 2 addresses scenarios involving trusts or foundations where the PDMR is the beneficiary.
- In some edge cases, such as piercing the corporate veil, a company set up purely for the benefit of its owner might also fall under this requisite.
3. Equivalent Economic Interests
- Requisite 3 is less straightforward and may include synthetic participations, profit-sharing arrangements, or certain extreme employee stock ownership plans.
4. Influence Over Transactions in Issuer’s Instruments
- Requisite 4 is often seen as cryptic. It generally concerns situations where a PDMR or PCA individual is also in a PDMR position within the entity, influencing its decisions to transact in the issuer’s instruments.
- According to ESMA, this requisite applies when a PDMR influences an entity’s transactions in the issuer’s securities. To avoid the risk of an entity becoming a PCA entity, a PDMR should ideally be excluded from voting or participating in discussions about such transactions.
Challenges in Determining PCA Entities
- While in most situations, it is straightforward to determine whether an entity qualifies as a PCA entity, complexities arise in the context of complex corporate structures or family relations.
- Legal ambiguity in these cases often requires careful analysis and expert advice.
Conclusion
In conclusion, the classification of PCA entities under MAR can be relatively clear in straightforward cases, but there are numerous edge cases where the legal situation remains uncertain. To ensure compliance, PDMRs and issuers must conduct thorough analyses and seek expert guidance, particularly in scenarios involving intricate corporate structures or family relationships.
Manage legal entities under MAR effortlessly—book a demo today to simplify processes with Logwise.
EU Listing Act – Implications for MAR and Insider Lists
The Act was published 14 November 2024 and entered into force on 4 December 2024. Its changes to MAR are rolled out in two waves, with three different effective dates: 4 December […]
EU Listing Act – Implications for MAR and Insider Lists
The Act was published 14 November 2024 and entered into force on 4 December 2024. Its changes to MAR are rolled out in two waves, with three different effective dates: 4 December […]
EU Listing Act – Implications for MAR and Insider Lists – 4 December 2024
The Act was published 14 November 2024 and entered into force on 4 December 2024. Its changes to MAR are rolled out in two waves, with two different effective dates: 4 December […]
Revised Conditions for Delaying Disclosure
The delay mechanism (under Art. 17(4)) is retained, but one of the three conditions has been amended. The previous condition – that delay is “not likely to mislead the public” – is […]
Protracted Processes: Disclosure Only on the Final Event
Under the pre-June 2026 rules: Issuers have been required to disclose inside information arising at each intermediate step of a protracted process (such as e.g. ongoing merger negotiations, a capital raise, or […]
